These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 7253832)

  • 1. Striatal muscarinic receptors: regulation by dopaminergic agonists.
    Ehlert FJ; Roeske WR; Yamamura HI
    Life Sci; 1981 May; 28(21):2441-8. PubMed ID: 7253832
    [No Abstract]   [Full Text] [Related]  

  • 2. Dopaminergic regulation of muscarinic receptor binding in the corpus striatum.
    Ehlert FJ; Roeske WR; Yamamura HI
    Proc West Pharmacol Soc; 1981; 24():93-5. PubMed ID: 7255494
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of long-term L-dopa administration on the dopaminergic and cholinergic (muscarinic) receptors of striatum in 6-hydroxydopamine lesioned rats.
    Suga M
    Life Sci; 1980 Sep; 27(10):877-82. PubMed ID: 7412476
    [No Abstract]   [Full Text] [Related]  

  • 4. Muscarinic cholinergic binding in striatal and mesolimbic areas of the rat: reduction by 6-hydroxydopa.
    Nomura Y; Kajiyama H; Nakata Y; Segawa T
    Eur J Pharmacol; 1979 Sep; 58(2):125-31. PubMed ID: 499342
    [No Abstract]   [Full Text] [Related]  

  • 5. Identification of direct competition for, and indirect influences on, striatal muscarinic cholinergic receptors: in vivo [3H]quinuclidinyl benzilate binding in rats.
    Pelham RW; Munsat TL
    Brain Res; 1979 Aug; 171(3):473-80. PubMed ID: 476482
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An enhanced sensitivity of muscarinic cholinergic receptor associated with dopaminergic receptor subsensitivity after chronic antidepressant treatment.
    Koide T; Matsushita H
    Life Sci; 1981 Mar; 28(10):1139-45. PubMed ID: 7231043
    [No Abstract]   [Full Text] [Related]  

  • 7. Chronic fluphenazine and clozapine elicit opposite changes in brain muscarinic receptor binding: implications for understanding tardive dyskinesia.
    Friedman E; Gianutsos G; Kuster J
    J Pharmacol Exp Ther; 1983 Jul; 226(1):7-12. PubMed ID: 6864552
    [No Abstract]   [Full Text] [Related]  

  • 8. Properties and distribution of muscarinic cholinergic receptors in rat striatal micropunched tissue homogenates.
    Takano Y; Uchimura K; Kohjimoto Y; Kamiya H
    Eur J Pharmacol; 1981 Apr; 70(4):559-64. PubMed ID: 7238577
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dopamine D2 and muscarinic receptor binding characteristics in rat brain after withdrawal of subchronic fluphenazine and sulpiride treatment.
    Hietala J; Syvälahti E; Röyttä M
    Prog Neuropsychopharmacol Biol Psychiatry; 1989; 13(1-2):247-58. PubMed ID: 2526352
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Muscarinic receptor-mediated regulation of OM-853-enhanced dopamine release in striatum of rat.
    Koda H; Hashimoto T; Kuriyama K
    Eur J Pharmacol; 1989 Mar; 162(3):501-8. PubMed ID: 2744083
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of the distribution of acetylcholinesterase and muscarinic cholinergic receptors in the feline neostriatum.
    Brand S
    Neurosci Lett; 1980 Apr; 17(1-2):113-7. PubMed ID: 7052452
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of acute and chronic cholinesterase inhibition with diisopropylfluorophosphate on muscarinic, dopamine, and GABA receptors of the rat striatum.
    Sivam SP; Norris JC; Lim DK; Hoskins B; Ho IK
    J Neurochem; 1983 May; 40(5):1414-22. PubMed ID: 6300336
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [3H]spiperone and [3H]quinuclidinyl benzilate binding in striatal membranes from rats chronically treated with manganese chloride throughout development and for over two years.
    Leung TK; Lai JC; Lim L
    Gen Pharmacol; 1986; 17(1):121-3. PubMed ID: 3949146
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alterations of striatal cholinergic receptors after lesioning of the substantia nigra.
    Sanvarinda Y; Phivthongngam L; Govitrapong P
    Neurochem Int; 1998 Aug; 33(2):187-93. PubMed ID: 9761463
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevention of fluphenazine-induced changes in dopaminergic and muscarinic receptors by lithium.
    Gianutsos G; Friedman E
    Pharmacol Biochem Behav; 1987 Mar; 26(3):635-7. PubMed ID: 3575380
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of lesions in the parafascicular nucleus on catecholamine synthesis and number of muscarinic receptor binding sites in the striatum of the rat.
    Ahlenius S; Nordberg A
    Acta Pharmacol Toxicol (Copenh); 1982 Sep; 51(3):182-6. PubMed ID: 6127863
    [No Abstract]   [Full Text] [Related]  

  • 17. Pharmacologic identification of muscarinic receptors in the pylorus of the cat by binding of [3H]-quinuclidinyl benzilate.
    Gaginella TS; Rimele TJ; O'Dorisio TM; Dorff RJ
    Life Sci; 1980 May; 26(19):1599-608. PubMed ID: 7382732
    [No Abstract]   [Full Text] [Related]  

  • 18. Specific inhibition of dopamine D-1-mediated cyclic AMP formation by dopamine D-2, muscarinic cholinergic, and opiate receptor stimulation in rat striatal slices.
    Kelly E; Nahorski SR
    J Neurochem; 1986 Nov; 47(5):1512-6. PubMed ID: 2428936
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Downregulation of muscarinic receptors in the rat caudate-putamen after lesioning of the ipsilateral nigrostriatal dopamine pathway with 6-hydroxydopamine (6-OHDA): normalization by fetal mesencephalic transplants.
    Dawson TM; Dawson VL; Gage FH; Fisher LJ; Hunt MA; Wamsley JK
    Brain Res; 1991 Feb; 540(1-2):145-52. PubMed ID: 1905173
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in brain muscarinic acetylcholine receptors and behavioral responses to atropine and apomorphine in chronic atropine-treated rats.
    Takeyasu K; Uchida S; Noguchi Y; Fujita N; Saito K; Hata F; Yoshida H
    Life Sci; 1979 Aug; 25(7):585-92. PubMed ID: 502751
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.